University of Maryland, Baltimore
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Maryland, Baltimore sits in the top decile of US sponsors by registered trial count (#62 of 15,742 sponsors by registered trial count).
University of Maryland, Baltimore: 560 sponsored US clinical trials, 103 recruiting.
University of Maryland, Baltimore sponsors 560 registered US clinical trials on ClinicalTrials.gov, 103 of them currently recruiting, and 332 completed. 77 of these trials are in Phase 3-4 (later-stage) and 161 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Schizophrenia, with 14 trials.
Top-decile sponsor footprint
University of Maryland, Baltimore ranks in the top decile of sponsors by registered trial count (#62 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
332 of 410 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
560 total, page 8 of 12
Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients
NCT02428244
Oxytocin, Emotions and Mirror Neurons
NCT02228031
Transdermal Patch CVD 1000: The Effect of Heat on Nicotine Release From Nicotine Patches in Adult Smokers
NCT02371850
Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity
NCT02118610
Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine
NCT02420327
Tryptophan MRI in People With Schizophrenia and Healthy Controls
NCT02067975
Human Microbiome and Healthcare Associated Infections - Nursing Home Dwelling Older Veterans
NCT04218799
Metabolic Actions of Omega-3 Fatty Acids
NCT01896414
MediHoney for Radiation Dermatitis
NCT02234479
Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
NCT04195438
Care Coordination/Home Telehealth to Safeguard Care in CKD
NCT03038126
Optune(NOVOTTF-100A)+ Bevacizumab+ Hypofractionated Stereotactic Irradiation Bevacizumab-Naive Recurrent Glioblastoma (GCC 1344)
NCT01925573
A Phase 1, Open-Label Study of Intravenous Sildenafil in Patients With Cirrhosis
NCT01954524
MICRO Study: Detecting Bacterial Infections Related to Orthopaedic Surgical Implants
NCT03132246
Improving Heart Failure Outcomes Rural
NCT02395588
Biological Evaluation of Dietary Supplement Liposomal Glutathione
NCT01967667
1380GCC: Prospective Study of GP-88 Blood Test in Healthy Women With Baseline Gail Model Risk Assessment Undergoing Screening for Breast Cancer
NCT02700776
Borderline Pancreas Study: FOLFIRINOX +SBRT
NCT01992705
Oxytocin and CBSST for People With Schizophrenia
NCT01752712
1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
NCT02000596
Ultra Coils From Start to Finish for the Endovascular Repair of Small Intracranial Aneurysms
NCT02657772
Randomized Controlled Trial of a Gluten Free Diet In Patients With Schizophrenia Who Are Gliadin-Positive
NCT01927276
Tobacco Craving and Triggers in Persons With Schizophrenia
NCT01846065
Neuroendocrine and Immune Response to Stress in Schizophrenia
NCT01975584
MedActive: A Smartphone Intervention to Improve Adherence to Antipsychotic Medications
NCT01953237
Switch to Maraviroc + Integrase Inhibitor
NCT01896921
4D-CT for Pancreatic Adenocarcinoma in Radiotherapy Simulation
NCT01764659
Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
NCT01778634
Improving Community Ambulation After Hip Fracture
NCT01783704
Spray Cryotherapy for Esophageal Cancer (ICE-CANCER)
NCT01868139
Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial
NCT01756833
The Family VOICE Study
NCT01804582
Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
NCT01822275
Intestinal Permeability in Preterm Infants
NCT01756040
Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)
NCT01881932
Impact of Formulation on Ciprofloxacin Oral Absorption
NCT00992329
Early Elimination of Premature Ventricular Contractions in Heart Failure
NCT01757067
Acupuncture in Reducing the Severity of Chemoradiation-induced Mucositis in Patients With Oropharyngeal Cancer
NCT01883908
Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)
NCT01672255
Pharmacokinetic and Safety Evaluation of L-tetrahydropalmatine (l-THP) With Cocaine Exposure in People With a History of Cocaine Use
NCT01631383
Breast Cup Immobilization Device II (GCC 1047)
NCT01704547
Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD)
NCT01692743
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
NCT01408641
Assessment of End Expiratory Lung Volumes in Healthy Subjects Using High Flow Oxygen (Vapotherm®)
NCT01672242
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients
NCT01650545
Effects of Intranasal Oxytocin on Satiety Signaling in People With Schizophrenia
NCT01614093
Anti-Inflammatory Treatment of Schizophrenia
NCT01514682
Lamotrigine Bioequivalence
NCT01995825
Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
NCT01499160
Hand Hygiene Before Non-sterile Glove Use
NCT01571778
What is open in the University of Maryland, Baltimore pipeline
103 recruiting of 560 indexed (18% open); 332 completed (59%).
Phase mix: 77 late (III/IV) vs 161 early (I/II) (early-phase heavy).
Top condition: Schizophrenia (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Maryland, Baltimore: open-pipeline peers nationwide
Peers matched on 560 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of Maryland, Baltimore sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 560 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- Virginia Commonwealth University · 558 trials · 14% recruiting
- National Institute of Neurological Disorders and Stroke (NINDS) · 567 trials · 8% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- Henry Ford Health System · 18% recruiting · 234 trials
- New York Institute of Technology · 18% recruiting · 49 trials
- University of California, San Diego · 18% recruiting · 775 trials
Related
What to do with this University of Maryland, Baltimore page
560 registered trials is a research-attention snapshot, not an endorsement of University of Maryland, Baltimore or any single study.
- 103 of University of Maryland, Baltimore's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Schizophrenia is the condition University of Maryland, Baltimore studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Schizophrenia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Maryland, Baltimore pipeline card: 560 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.